COMPANY PROFILE

Science Exchange

Explore full profile

Order experiments from the world's best labs

Palo Alto, United StatesFounded 2011Biotech & Life Sciences

Valuation $50–100M Last recorded · 2019

Revenue $10–50M Latest reported FY

Headcount 100–500 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Science Exchange

Science Exchange operates a comprehensive marketplace for scientific services, enabling research teams to source, order, and pay for services from over 3,500 Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), and academic labs. The platform serves clients in the life sciences sector, including biopharmaceutical companies, medical device manufacturers, and agriscience firms. By consolidating multiple service providers under one Master Service Agreement (MSA), Science Exchange simplifies the procurement process, accelerates research timelines, and reduces costs. The company generates revenue through transaction fees and subscription models, providing a seamless integration with ERP, procurement, and file storage systems to maintain security and compliance.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2011
Headquarters: Palo Alto, United States
Employees: 117
Open positions: 2
Dealroom signal: 84.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Enterprise Resource Planning, Synthetic Biology, Experiment, Biotech and Pharma, Hard Tech, YC S11
Business model: Marketplace & ecommerce
Client focus: b2c
Investment activity: 2 companies, latest Mar 2025
Capital deployed: —
Preferred round: ACQUISITION
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

9 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
BUYOUTOther financing	Sep 2024	$0	—	Waud Capital Partners	↗
LATE VCOther financing	Oct 2019	$20M	$80M	Collaborative Fund · OATV · Maverick Ventures · Silicon Valley Bank	—

Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Science Exchange website traffic

Latest recorded traffic for Science Exchange is 3.3K monthly website visits, down 58.2% over the last three months. Science Exchange's team grew 2.6% over the past year.

Latest monthly visits3.3K 3-month web change-58.2% 1-year team growth+2.6%

Monthly website visitsApr 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
VIVigene Biosciences Inc.Vigene Biosciences - Excellence in Gene Delivery	Rockville, United States	Acquired	30	$10M	$293M
GBGreenlight BiosciencesGreenLight Biosciences employs the Unconstrained Metabolism(R) technology platform to produce sustainable chemicals and fuels	Medford, United States	Acquired
PBPioneer BiolabsB2B biomanufacturing company leveraging its proprietary genomic screening platform to engineer and optimize microbial cells for protein production	Provo, United States	Operational
LOLogomixLarge-scale genome engineering platform for cell therapy	Tokyo, Japan	Operational
EUEureKAREInvestment firm dedicated to funding and advancing synthetic biology innovations throughout Europe	Paris, France	Closed
CECentivaxA healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services	South San Francisco, United States	Operational
NANanoSyrinxA cutting-edge synthetic biology company creating the next generation of targeted drug delivery systems to address challenges in the biologic delivery sector	Coventry, United Kingdom	Operational
PBProvenance BioDeveloped a cutting edge synthetic biology platform to compete head-to-head with animal proteins, today making collagen	San Francisco, United States	Operational